High-Mobility Group Box 1 Overexpression Predicts a Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Gastric Cancer by Activating TLR4/NF-κB Signaling
Jichun Ma et al, 2023, Oncology CrossRef
Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications
Aditya Sri Listyoko et al, 2024, Frontiers in Allergy CrossRef
Glycyrrhizin suppresses epithelial-mesenchymal transition by inhibiting high-mobility group box1 via the TGF-β1/Smad2/3 pathway in lung epithelial cells
Yanni Gui et al, 2020, PeerJ CrossRef
Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer
María Cámara-Quílez et al, 2020, Current Medicinal Chemistry CrossRef
Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
Nurbubu T. Moldogazieva et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
Unresolved Complexity in the Gene Regulatory Network Underlying EMT
Deborah P. Lavin et al, 2020, Frontiers in Oncology CrossRef
Research Progress of HMGB1 and NF-κB in Cancer
志昂潘, 2023, Advances in Clinical Medicine CrossRef
The RAGE/multiligand axis: a new actor in tumor biology
Armando Rojas et al, 2022, Bioscience Reports CrossRef
Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
Jens Staal et al, 2018, Cells CrossRef
Multiple functions of HMGB1 in cancer
Guangyao Lv et al, 2024, Frontiers in Oncology CrossRef
Receptor for advanced glycation end‐products: Biological significance and imaging applications
Iwona T. Dobrucki et al, 2024, WIREs Nanomedicine and Nanobiotechnology CrossRef
Diabetes Driven Oncogenesis and Anticancer Potential of Repurposed Antidiabetic Drug: A Systemic Review
Iqra Khan et al, 2024, Cell Biochemistry and Biophysics CrossRef
Circular RNA 0081146 facilitates the progression of gastric cancer by sponging miR-144 and up-regulating HMGB1
Qihua Xu et al, 2021, Biotechnology Letters CrossRef